No Data
No Data
No Data
Cansino Biologics Inc. (688185.SH): The necessary preparatory work for the clinical application of the upgraded version of the combined disease-strengthening vaccine is being carried out in Indonesia.
Cansino Biologics Inc. (688185.SH) stated on the investor interaction platform on June 19th that the necessary preclinical work for the company's combination disease-enhanced vaccine (upgraded version) to apply for clinical approval in Indonesia is underway.
Cansino Biologics Inc. (688185.SH): Clinical trials for quadrivalent meningococcal combination vaccine expansion have completed enrollment.
Cansino Biologics Inc. (688185.SH) stated on the investor interactive platform on June 19 that the expanded clinical study of the company's four-valent meningo combination vaccine for the 4-6 year old age group has completed enrollment and is currently undergoing follow-up visits and sample collection according to plan.
Is CanSino Biologics (HKG:6185) Using Debt Sensibly?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's balance sheet when you examine how risky it is, since debt is often involved whe
Cansino Biotech (06185) proposes to appoint Li Zhi as a non-executive director
Cansino Biotech (06185) announced that Liang Yuyu has resigned as a non-executive director and board of directors due to personal work reasons...
Changes in Hong Kong stocks | Cansino Biotech (06185) rose more than 9%, once again drawing attention to the company's rich research pipeline
Cansino Biotech (06185) rose more than 9%. As of press release, it rose 9.84% to HK$23.45, with a turnover of HK$41.775,800.
Hong Kong Stock Concept Tracking | US Confirms Second Case of Human Infection with Avian Influenza Vaccine Sector Receives Attention (with concept stocks)
On May 22, local time, according to reports from local health officials, the US state of Michigan has confirmed the state's second case of human infection with bird flu. The infected person was a farm worker who had mild symptoms and quickly recovered after being infected. According to reports, this is the third case of bird flu reported across the US this year. Last month, a farm worker in the southern US state of Texas developed symptoms such as red eyes after being exposed to sick cows. This is the first case of bird flu in the US this year. The US side confirmed the second case of human infection with bird flu on Wednesday. Affected by this, vaccine concept stocks rose across the board. BioNTech was up 11.1% by the close, CureV
No Data